Switching to an AI following 2–3 years of initial adjuvant tamoxifen is an effective option for patients unable to begin treatment with an AI. This article evaluates the most up-to-date results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback